171 related articles for article (PubMed ID: 28826666)
21. HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.
Meikle PJ; Formosa MF; Mellett NA; Jayawardana KS; Giles C; Bertovic DA; Jennings GL; Childs W; Reddy M; Carey AL; Baradi A; Nanayakkara S; Wilson AM; Duffy SJ; Kingwell BA
J Am Heart Assoc; 2019 Jun; 8(11):e011792. PubMed ID: 31131674
[TBL] [Abstract][Full Text] [Related]
22. Circulating non-HDL-C levels were more relevant to atherogenic lipoprotein subfractions compared with LDL-C in patients with stable coronary artery disease.
Zhu CG; Zhang Y; Xu RX; Li S; Wu NQ; Guo YL; Sun J; Li JJ
J Clin Lipidol; 2015; 9(6):794-800. PubMed ID: 26687700
[TBL] [Abstract][Full Text] [Related]
23. Identification and characterization of a rare variant in apolipoprotein A-IV, p.(V336M), and evaluation of HDL functionality in a Greek cohort with extreme HDL cholesterol levels.
Chroni A; Rallidis L; Vassou D; Gkolfinopoulou C; Papakosta P; Zervou MI; Goulielmos GN; Kiouri E; Pappa D; Eliopoulos E; Kardassis D
Arch Biochem Biophys; 2020 Dec; 696():108655. PubMed ID: 33130088
[TBL] [Abstract][Full Text] [Related]
24. Relation of oxidized-low-density lipoprotein and high-density lipoprotein subfractions in non-treated patients with coronary artery disease.
Zhao X; Zhang HW; Sun D; Xu RX; Guo YL; Sun J; Zhu CG; Wu NQ; Zhang Y; Li S; Li JJ
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106345. PubMed ID: 31278984
[TBL] [Abstract][Full Text] [Related]
25. Untargeted Lipidomics Reveals a Specific Enrichment in Plasmalogens in Epicardial Adipose Tissue and a Specific Signature in Coronary Artery Disease.
Barchuk M; Dutour A; Ancel P; Svilar L; Miksztowicz V; Lopez G; Rubio M; Schreier L; Nogueira JP; Valéro R; Béliard S; Martin JC; Berg G; Gaborit B
Arterioscler Thromb Vasc Biol; 2020 Apr; 40(4):986-1000. PubMed ID: 32102570
[TBL] [Abstract][Full Text] [Related]
26. Atherosclerotic cardiovascular disease in hyperalphalipoproteinemia due to LIPG variants.
Cole J; Blackhurst DM; Solomon GAE; Ratanjee BD; Benjamin R; Marais AD
J Clin Lipidol; 2021; 15(1):142-150.e2. PubMed ID: 33414088
[TBL] [Abstract][Full Text] [Related]
27. Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease.
Attia N; Nakbi A; Smaoui M; Chaaba R; Moulin P; Hammami S; Hamda KB; Chanussot F; Hammami M
Tohoku J Exp Med; 2007 Oct; 213(2):129-37. PubMed ID: 17917406
[TBL] [Abstract][Full Text] [Related]
28. Free cholesterol concentrations in the high-density lipoprotein subfraction-3 as a risk indicator in patients with angiographically documented coronary artery disease.
Smuts CM; Weich HF; Weight MJ; Faber M; Kruger M; Lombard CJ; Benadé AJ
Coron Artery Dis; 1994 Apr; 5(4):331-8. PubMed ID: 8044345
[TBL] [Abstract][Full Text] [Related]
29. Involvement of CETP (Cholesteryl Ester Transfer Protein) in the Shift of Sphingosine-1-Phosphate Among Lipoproteins and in the Modulation of its Functions.
Kurano M; Hara M; Ikeda H; Tsukamoto K; Yatomi Y
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):506-514. PubMed ID: 28126827
[TBL] [Abstract][Full Text] [Related]
30. Quantity and function of high density lipoprotein as an indicator of coronary atherosclerosis.
Saku K; Zhang B; Ohta T; Arakawa K
J Am Coll Cardiol; 1999 Feb; 33(2):436-43. PubMed ID: 9973024
[TBL] [Abstract][Full Text] [Related]
31. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
[TBL] [Abstract][Full Text] [Related]
32. Serum high-density lipoprotein-cholesterol levels modify the association between plasma levels of oxidatively modified low-density lipoprotein and coronary artery disease in men.
Zhang B; Bai H; Liu R; Kumagai K; Itabe H; Takano T; Saku K
Metabolism; 2004 Apr; 53(4):423-9. PubMed ID: 15045686
[TBL] [Abstract][Full Text] [Related]
33. The two novel CETP mutations Gln87X and Gln165X in a compound heterozygous state are associated with marked hyperalphalipoproteinemia and absence of significant coronary artery disease.
Rhyne J; Ryan MJ; White C; Chimonas T; Miller M
J Mol Med (Berl); 2006 Aug; 84(8):647-50. PubMed ID: 16855848
[TBL] [Abstract][Full Text] [Related]
34. Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease.
You J; Wang Z; Lu G; Chen Z
Biomed Res Int; 2020; 2020():7146028. PubMed ID: 32219140
[TBL] [Abstract][Full Text] [Related]
35. High-density lipoprotein subclass profile and mortality in patients with coronary artery disease: Results from the GENES study.
Elbaz M; Faccini J; Bongard V; Ingueneau C; Taraszkiewicz D; Perret B; Ferrières J; Ruidavets JB; Vindis C
Arch Cardiovasc Dis; 2016 Nov; 109(11):607-617. PubMed ID: 27693051
[TBL] [Abstract][Full Text] [Related]
36. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
[TBL] [Abstract][Full Text] [Related]
37. Plasma high density lipoproteins and coronary artery disease.
Sodhi HS; Lee G; Joye JA; Clifford CK; Kudchodkar BJ; Terai Y; Shaw I; Mason DT
Adv Myocardiol; 1980; 2():513-25. PubMed ID: 7423063
[TBL] [Abstract][Full Text] [Related]
38. Sex differences in lipidomic and bile acid plasma profiles in patients with and without coronary artery disease.
Bay B; Fuh MM; Rohde J; Worthmann A; Goßling A; Arnold N; Koester L; Lorenz T; Blaum C; Kirchhof P; Blankenberg S; Seiffert M; Brunner FJ; Waldeyer C; Heeren J
Lipids Health Dis; 2024 Jun; 23(1):197. PubMed ID: 38926753
[TBL] [Abstract][Full Text] [Related]
39. Common variants in the genes of triglyceride and HDL-C metabolism lack association with coronary artery disease in the Pakistani subjects.
Shahid SU; Shabana NA; Cooper JA; Rehman A; Humphries SE
Lipids Health Dis; 2017 Jan; 16(1):24. PubMed ID: 28143480
[TBL] [Abstract][Full Text] [Related]
40. Myeloperoxidase mediated HDL oxidation and HDL proteome changes do not contribute to dysfunctional HDL in Chinese subjects with coronary artery disease.
Wang G; Mathew AV; Yu H; Li L; He L; Gao W; Liu X; Guo Y; Byun J; Zhang J; Chen YE; Pennathur S
PLoS One; 2018; 13(3):e0193782. PubMed ID: 29505607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
